Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of chronic and genetic diseases
3.2.1.2 Technological advancement in cell therapy
3.2.1.3 Increasing investment in research & development activities
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory challenges
3.2.2.2 Complexity of cell therapy development
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Service, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Clinical trial design & planning
5.3 Supply & logistics services
5.4 Regulatory affairs & compliance
5.5 Data management & biostatistics
5.6 Site management & monitoring
5.7 Other services
Chapter 6 Market Estimates and Forecast, By Phase, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Phase I
6.3 Phase II
6.4 Phase III
6.5 Phase IV
Chapter 7 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Oncology
7.3 Hematology
7.4 Neurology
7.5 Cardiovascular diseases
7.6 Musculoskeletal disorders
7.7 Other indications
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical & biotechnology companies
8.3 Contract research organizations
8.4 Academic & research institutes
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 ICON PLC
10.2 IQVIA
10.3 Medpace, Inc.
10.4 Laboratory Corporation of America Holdings
10.5 Parexel International
10.6 Worldwide Clinical Trials
10.7 Charles River Laboratories International, Inc.
10.8 Syneos Health
10.9 Thermo Fisher Scientific Inc.
10.10 Novotech
10.11 Catalent Pharma
10.12 Precision Medicine Group, LLC
